Physician profile
Daniel Choo
NPI 1447270053
$7,000.02
in general payments reported to CMS, 2019-2025
8 companies · $18.80 in 2025
The $18.80 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2022: $4,329 · 2023: $369 · 2024: $2,148 · 2025: $18.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,000 · Food and Beverage: $428 · Travel and Lodging: $108.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,000.00 |
| Food and Beverage | $427.73 |
| Travel and Lodging | $107.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cook Medical LLC | $4,218.81 | 2022 | |
| Eli Lilly and Company | $2,166.18 | 2023-2024 | |
| Stryker Corporation | $180.55 | 2019-2023 | Core |
| 3nt Medical | $171.00 | 2022-2023 | |
| Advanced Bionics, LLC | $166.64 | 2024-2025 | Hires Ultra Ci Hifocus Ms Electrode |
| Med-El Corporation | $74.25 | 2023 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Abbott Laboratories | $22.59 | 2023 | Portico |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$24,880.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Choo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.